Folgen
Pere-Joan Cardona
Pere-Joan Cardona
Chief of the Microbiology Department, Hospital "Germans Trias i Pujol". Badalona, Catalonia (Spain)
Bestätigte E-Mail-Adresse bei gencat.cat - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Foamy macrophages and the progression of the human tuberculosis granuloma
DG Russell, PJ Cardona, MJ Kim, S Allain, F Altare
Nature immunology 10 (9), 943-948, 2009
10432009
Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence
P Peyron, J Vaubourgeix, Y Poquet, F Levillain, C Botanch, F Bardou, ...
PLoS pathogens 4 (11), e1000204, 2008
8732008
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
U Mack, GB Migliori, M Sester, HL Rieder, S Ehlers, D Goletti, A Bossink, ...
European Respiratory Journal 33 (5), 956-973, 2009
8442009
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
C Aagaard, T Hoang, J Dietrich, PJ Cardona, A Izzo, G Dolganov, ...
Nature medicine 17 (2), 189-194, 2011
6522011
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015
HH Kyu, ER Maddison, NJ Henry, JE Mumford, R Barber, C Shields, ...
The Lancet Infectious Diseases 18 (3), 261-284, 2018
3932018
The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs
C Martin, A Williams, R Hernandez-Pando, PJ Cardona, E Gormley, ...
Vaccine 24 (17), 3408-3419, 2006
3092006
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
A Arbues, JI Aguilo, J Gonzalo-Asensio, D Marinova, S Uranga, ...
Vaccine 31 (42), 4867-4873, 2013
2952013
Risk factors for lower airway bacterial colonization in chronic bronchitis
E Monso, A Rosell, G Bonet, J Manterola, PJ Cardona, J Ruiz, J Morera
European Respiratory Journal 13 (2), 338-342, 1999
2661999
Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis
C Vilaplana, E Marzo, G Tapia, J Diaz, V Garcia, PJ Cardona
The Journal of infectious diseases 208 (2), 199-202, 2013
2432013
RUTI: a new chance to shorten the treatment of latent tuberculosis infection
PJ Cardona
Tuberculosis 86 (3-4), 273-289, 2006
2282006
Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
C Vilaplana, E Montané, S Pinto, AM Barriocanal, G Domenech, F Torres, ...
Vaccine 28 (4), 1106-1116, 2010
1882010
A dynamic reinfection hypothesis of latent tuberculosis infection
PJ Cardona
Infection 37, 80-86, 2009
1832009
The burden of disease in Spain: Results from the Global Burden of Disease 2016
JB Soriano, D Rojas-Rueda, J Alonso, JM Anto, PJ Cardona, ...
Medicina Clínica (English Edition) 151 (5), 171-190, 2018
1682018
Patogénesis de la tuberculosis y otras micobacteriosis
PJ Cardona
Enfermedades infecciosas y microbiologia clinica 36 (1), 38-46, 2018
1682018
Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in …
F Gamboa, G Fernandez, E Padilla, JM Manterola, J Lonca, PJ Cardona, ...
Journal of clinical microbiology 36 (3), 684-689, 1998
1601998
Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis …
AS Nell, E D’lom, P Bouic, M Sabate, R Bosser, J Picas, M Amat, ...
PloS one 9 (2), e89612, 2014
1502014
Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis
PJ Cardona, R Llatjos, S Gordillo, J Diaz, I Ojanguren, A Ariza, V Ausina
Scandinavian journal of immunology 52 (2), 156-163, 2000
1472000
On the nature of Mycobacterium tuberculosis-latent bacilli
PJ Cardona, J Ruiz-Manzano
European Respiratory Journal 24 (6), 1044-1051, 2004
1462004
Towards host-directed therapies for tuberculosis
A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ...
Nature reviews Drug discovery 14 (8), 511-512, 2015
1352015
Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection
D Di Liberto, M Locati, N Caccamo, A Vecchi, S Meraviglia, A Salerno, ...
The Journal of experimental medicine 205 (9), 2075-2084, 2008
1352008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20